Summary
  • Multi-target molecules 315
  • Clinical molecules 0
  • Avg pChEMBL 7.76
Top Co-occurrence Targets
Active Molecules (315)
InChIKey pChEMBL Type Targets Clinical
LUULFVMVNHPTMD 7.4 IC50 4
QKXAPDZEXRNRNW 7.4 Ki 2
RKSGIDSCASKYQC 7.4 IC50 4
SVIJSFDDCORCGI 7.4 IC50 4
TUHFONVJWAMROS 7.4 Ki 2
VMGAVHOARRCARD 7.4 IC50 4
YAFHDFSMUJSRRC 7.4 IC50 4
KJJKIDWSYKGDGR 7.4 Ki 2
LELTXNSBXZXYHC 7.3 IC50 4
NHNUZULGAZMHGX 7.3 IC50 4
KMSQBSNTZXIOAQ 7.3 Ki 2
QNVCYCOYQOYHKP 7.3 Ki 3
FDUWMNSSRXYVAE 7.3 Ki 2
GOJLWYJGIGTXFP 7.3 Ki 2
LVYYVTSPFCAYQP 7.3 Ki 2
OVLREHIDVJYZJD 7.3 IC50 4
YAPCTVNKWVWBJJ 7.3 Ki 2
ZHVMEZXHKSSDJL 7.3 Ki 2
VAQVHYUGAUVNMW 7.3 Ki 2
ACYQAVZVIPDFCX 7.3 IC50 4
OLFGJSPMJIHIKO 7.3 Ki 2
VWGQMMYCGJMUAB 7.3 IC50 4
FQWQFMJDELOUET 7.2 Ki 2
VARBFZKEJMFXSC 7.2 Ki 3
YSAPFUUTPOKROX 7.2 Ki 2
PFUMEOBJFIZGIN 7.2 Ki 2
XADSZCMEQSIZJY 7.2 IC50 4
XHJKCFKNHZQLKU 7.2 Ki 2
ZKAQIUCIWWKTNI 7.2 Ki 2
ZPKDOCXSELIIGV 7.2 Ki 2
DAQVNZCLEDKUSD 7.2 IC50 4
HUYACAOSSLGCFG 7.2 IC50 4
SBQMQLFREOTOLJ 7.2 IC50 4
TUGCYOIYHXSOKI 7.2 IC50 4
ZKELQISUOPVZIB 7.2 IC50 4
CSOCTFLGSKTNFD 7.2 Ki 2
QANSKWRZMQTBLX 7.2 IC50 4
RBMZJAAUGKQFBX 7.2 IC50 4
XGAYJOVUJFIQOJ 7.2 IC50 4
WLORIZRWVLDMDY 7.2 Ki 2
ZZXAHCFXKSIAQP 7.2 Ki 2
DMXZRMUVJBHDST 7.1 IC50 4
QOQJFKFSWFUVKP 7.1 Ki 2
JFZUXQLHWZVVAG 7.1 Ki 2
PNJHHRKKKXJSKO 7.1 IC50 4
SKBNPHMFNYRNKO 7.1 IC50 4
IYLFCYFVRLIDTA 7.1 Ki 2
YFYHDVOVFZQTQE 7.1 Ki 2
CBATWNWELXWLJU 7.1 Ki 2
SANAKVHOEONSCW 7.0 Ki 2
2D structure